Anap­tys­Bio touts PhI­II win in a rare form of pso­ri­a­sis. But it does­n't plan on keep­ing the drug

Last year
Deals
R&D

Astel­las pro­pos­es ‘More Not Flash­es' in first brand­ed ad for Veozah menopause treat­ment

Last year
Pharma
Marketing

Up­dat­ed: Two years on from con­fir­ma­to­ry tri­al halt, FDA sub­mits more ques­tions to On­copep­tides over Pepax­to ...

Last year
R&D
FDA+

Can­cer drug short­ages, sub­se­quent price hikes re­main a dark cloud over pa­tient care cen­ters

Last year
Manufacturing

Cal­i­for­nia gov­er­nor ve­toes bill to cap in­sulin prices at $35 per month

Last year
Pharma
FDA+

Bio­con’s in­sulin biosim­i­lar re­ject­ed yet again by FDA af­ter man­u­fac­tur­ing de­fi­cien­cies

Last year
Pharma
Manufacturing

Hamas strikes could im­pact some bio­phar­ma op­er­a­tions in Is­rael

Last year
R&D
Pharma

Scoop: No­var­tis ax­es mid-stage de­pres­sion tri­al of ke­t­a­mine-like in­jec­tion

Last year
R&D
Pharma

Re­turn of the megaround: Main Street Health rais­es $315M for val­ue-based care: #HLTH23

Last year
Financing
Health Tech

Bridge­Bio’s long-term limb-gir­dle mus­cu­lar dy­s­tro­phy da­ta; QHP buys a CD­MO

Last year
News Briefing

Uber and In­stacart ex­pand their health plan part­ner­ships

Last year
Health Tech

Why the CEO at North­well Health bets it can cre­ate the fu­ture of health­care rather than re­spond to it: #HLTH23

Last year
Health Tech

Ex­clu­sive: Ver­tex CSO David Alt­shuler talks non-opi­oid pain pills, AI and the myth of break­throughs

Last year
People
R&D

FDA re­jects Al­ny­lam’s On­pat­tro la­bel ex­pan­sion af­ter ad­comm vot­ed in fa­vor

Last year
R&D
Pharma

No­var­tis, Bris­tol My­ers back $61M Se­ries A raise for de­men­tia biotech As­tro­nauTx

Last year
Financing
Startups

Up­dat­ed: GSK taps Chi­nese part­ner to ramp up Shin­grix sales in $3.05B deal, with op­tion to ex­pand to RSV

Last year
Deals
China

An­timi­cro­bial re­sis­tance biotech se­cures $37M with ex-Cure­Vac CEO Franz-Wern­er Haas at the helm

Last year
Financing

Bris­tol My­ers makes a $4.8B bet on KRAS, strik­ing deal to ac­quire Mi­rati

Last year
Deals

Pi­o­neers of mR­NA win No­bel — plus our in­ter­view; Eli Lil­ly’s M&A, lead­er­ship shuf­fle; UniQure lay­offs as gene ...

Last year
Weekly

Gal­der­ma re­news an­nu­al breast can­cer aware­ness cam­paign with per­son­al sto­ries of sur­vivors

Last year
Pharma
Marketing

CBO analy­sis calls for more re­search in­to sav­ings po­ten­tial for obe­si­ty treat­ments

Last year
Pharma
FDA+

Pfiz­er and Ab­b­Vie oral mi­graine drugs earn top spots with physi­cians, sur­vey finds

Last year
Pharma
Marketing

Dis­counts for weight loss drugs are es­ti­mat­ed at more than half, fu­el­ing ques­tions about price, PBMs and cov­er­age

Last year
Pharma

Pfiz­er and BioN­Tech re­solve mR­NA patent law­suit filed by Pro­mo­some

Last year
Pharma
Law
First page Previous page 267268269270271272273 Next page Last page
A service from the Financial Times